← Back to search
POP BIOTECHNOLOGIES INC
BUFFALO, NY, 14228
UnclaimedClaim this profile (free)
Prime contracting experience
2 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | POP TECHNOLOGIES, INC., "MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE". | — | $599,806 | Sep 11, 2023 | Sep 30, 2023 – Sep 29, 2025 |
| Prime | Department of Health and Human Services National Institutes of Health | THE OBJECTIVE OF THIS CONTRACT IS TO UTILIZE A NEXT-GENERATION VACCINE ADJUVANT THAT INDUCES RAPID AND SERUM-STABLE SPONTANEOUS NANOLIPOSOME-ANTIGEN PARTICLEIZATION IN COMBINATION WITH MULTIPLE NATIVE FLEXIBLY LINKED (NFL) HIV ENVELOPE TRIMERS TO INDUCE HIGH LEVEL OF VIRUS-NEUTRALIZING ANTIBODIES FOLLOWING IMMUNIZATION. | — | $599,897 | Dec 27, 2022 | Jun 17, 2019 – Apr 30, 2023 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.